Measles outbreak in Americas
Analysis based on 6 articles · First reported Aug 10, 2026 · Last updated Aug 20, 2026
The outbreak may increase demand for measles vaccines and related healthcare services, potentially benefiting pharmaceutical companies and healthcare providers. However, it could strain public health systems and lead to increased government spending on immunization programs, with limited direct impact on broader financial markets.
The Americas are experiencing their worst measles outbreak in 22 years, with 47,459 confirmed cases and 44 deaths reported by July 18, 2026. This is more than three times the cases recorded in all of 2025. Guatemala, Mexico, the United States, and Peru account for 95% of cases, with Guatemala hardest hit at 30,371 cases and 26 deaths. The World Health Organization (PAHO) has classified the public health risk as very high due to ongoing transmission, suboptimal vaccination coverage, and increased population mobility. PAHO urges countries to strengthen vaccination, surveillance, and rapid outbreak response, emphasizing the need for at least 95% coverage with two doses of measles-containing vaccine. The outbreak reflects a global resurgence, with 186,168 cases reported worldwide by July 2026, a 12% increase from the same period in 2025. Vulnerable groups include unvaccinated children, Indigenous communities, migrants, and displaced populations.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard